MA29088B1 - Composes d'indazole-carboxamide. - Google Patents
Composes d'indazole-carboxamide.Info
- Publication number
- MA29088B1 MA29088B1 MA29976A MA29976A MA29088B1 MA 29088 B1 MA29088 B1 MA 29088B1 MA 29976 A MA29976 A MA 29976A MA 29976 A MA29976 A MA 29976A MA 29088 B1 MA29088 B1 MA 29088B1
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- indazole
- carboxamide compounds
- carboxamide
- preparing
- Prior art date
Links
- DITBWPUMEUDVLU-UHFFFAOYSA-N 1h-indazole-3-carboxamide Chemical class C1=CC=C2C(C(=O)N)=NNC2=C1 DITBWPUMEUDVLU-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 108091005482 5-HT4 receptors Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- DDMSOGRHSPMSLW-UHFFFAOYSA-N indazole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)N)N=CC2=C1 DDMSOGRHSPMSLW-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63880004P | 2004-12-22 | 2004-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA29088B1 true MA29088B1 (fr) | 2007-12-03 |
Family
ID=36295339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA29976A MA29088B1 (fr) | 2004-12-22 | 2007-06-08 | Composes d'indazole-carboxamide. |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7419989B2 (fr) |
| EP (1) | EP1831211B1 (fr) |
| JP (1) | JP5159317B2 (fr) |
| KR (1) | KR20070091665A (fr) |
| CN (1) | CN101080406A (fr) |
| AT (1) | ATE469897T1 (fr) |
| AU (1) | AU2005319190A1 (fr) |
| BR (1) | BRPI0519708A2 (fr) |
| CA (1) | CA2588037A1 (fr) |
| DE (1) | DE602005021696D1 (fr) |
| ES (1) | ES2347265T3 (fr) |
| IL (1) | IL183160A0 (fr) |
| MA (1) | MA29088B1 (fr) |
| MX (1) | MX2007007818A (fr) |
| NO (1) | NO20073182L (fr) |
| NZ (1) | NZ555180A (fr) |
| RU (1) | RU2404179C2 (fr) |
| WO (1) | WO2006069125A1 (fr) |
| ZA (1) | ZA200705115B (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070060606A1 (en) * | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
| TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| ATE441646T1 (de) * | 2004-11-05 | 2009-09-15 | Theravance Inc | 5-ht4-rezeptoragonistenverbindungen |
| JP5042028B2 (ja) * | 2004-11-05 | 2012-10-03 | セラヴァンス， インコーポレーテッド | キノリノン−カルボキサミド化合物 |
| US20060183901A1 (en) * | 2005-02-17 | 2006-08-17 | Theravance, Inc. | Crystalline form of an indazole-carboxamide compound |
| US7446114B2 (en) * | 2005-03-02 | 2008-11-04 | Theravance, Inc. | Quinolinone compounds as 5-HT4 receptor agonists |
| US7317022B2 (en) * | 2005-06-07 | 2008-01-08 | Theravance, Inc. | Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists |
| MY143574A (en) * | 2005-11-22 | 2011-05-31 | Theravance Inc | Carbamate compounds as 5-ht4 receptor agonists |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| ATE509021T1 (de) * | 2006-02-16 | 2011-05-15 | Theravance Inc | Verfahren zur herstellung von zwischenverbindungen zu 5-ht4-rezeptoragonist- verbindungen |
| JPWO2009101917A1 (ja) * | 2008-02-13 | 2011-06-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ビシクロアミン誘導体 |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011030349A1 (fr) | 2009-09-14 | 2011-03-17 | Suven Life Sciences Limited | Composés de 1,2-dihydro-2-oxoquinoléine comme ligands des récepteurs 5-ht4 |
| EP2531510B1 (fr) | 2010-02-01 | 2014-07-23 | Novartis AG | Dérivés de pyrazolo[5,1-b]utilisés en tant qu'antagonistes du récepteur de crf-1 |
| WO2011092293A2 (fr) | 2010-02-01 | 2011-08-04 | Novartis Ag | Dérivés de cyclohexylamide utilisés en tant qu'antagonistes du récepteur du crf |
| US8835444B2 (en) | 2010-02-02 | 2014-09-16 | Novartis Ag | Cyclohexyl amide derivatives as CRF receptor antagonists |
| US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| RU2013157374A (ru) * | 2011-06-07 | 2015-07-20 | Сумитомо Дайниппон Фарма Ко., Лтд. | Производное индазола и пирролопиридина и его фармацевтическое применение |
| KR20150003771A (ko) | 2012-05-03 | 2015-01-09 | 노파르티스 아게 | 그렐린 수용체 효능제로서의 2,7-디아자-스피로[4.5]데스-7-일 유도체의 l-말레이트 염 및 그의 결정질 형태 |
| JP2014133739A (ja) * | 2012-12-12 | 2014-07-24 | Dainippon Sumitomo Pharma Co Ltd | インダゾール誘導体またはピロロピリジン誘導体からなる医薬 |
| CA2932428C (fr) * | 2013-12-16 | 2017-10-24 | Suven Life Sciences Limited | Composes d'indazole en tant qu'agonistes de recepteur de 5-ht4 |
| WO2016014913A1 (fr) * | 2014-07-25 | 2016-01-28 | Innov17 Llc | Modulateurs indazoles du récepteur orphelin lié au récepteur de l'acide rétinoïque et leurs utilisations |
| CN106604921B (zh) * | 2014-08-16 | 2019-04-02 | 苏文生命科学有限公司 | 大规模生产1-异丙基-3-{5-[1-(3-甲氧基丙基)哌啶-4-基]-[1，3，4]噁二唑-2-基}-1h-吲唑草酸盐的方法 |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| US11833156B2 (en) | 2017-09-22 | 2023-12-05 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
| WO2019077631A1 (fr) | 2017-10-18 | 2019-04-25 | Jubilant Biosys Limited | Composés imidazo-pyridine à utiliser en tant qu'inhibiteurs de pad |
| KR20200085836A (ko) | 2017-11-06 | 2020-07-15 | 주빌런트 프로델 엘엘씨 | Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체 |
| BR112020010322A2 (pt) | 2017-11-24 | 2020-11-17 | Jubilant Episcribe Llc | composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer |
| CN112105610B (zh) | 2018-03-13 | 2024-01-26 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物 |
| JP2020199139A (ja) * | 2019-06-12 | 2020-12-17 | コニカミノルタ株式会社 | 制御装置、放射線撮影システム、制御方法及びプログラム |
| CN112805282A (zh) * | 2019-09-12 | 2021-05-14 | 广东东阳光药业有限公司 | 吲唑-甲酰胺衍生物及其用途 |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321378A (en) | 1979-01-16 | 1982-03-23 | Delalande S.A. | 8-(5-Pyrimidinecarboxamide)nor-tropane derivatives |
| DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | F. Hoffmann-La Roche Ag, Basel | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
| US4937247A (en) | 1985-04-27 | 1990-06-26 | Beecham Group P.L.C. | 1-acyl indazoles |
| GB8527052D0 (en) | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
| HU202108B (en) | 1986-07-30 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol |
| ES2036587T5 (es) | 1986-11-21 | 1995-10-16 | Glaxo Group Ltd | Medicamentos para el tratamiento o prevencion del sindrome de abstinencia. |
| GB8701022D0 (en) | 1987-01-19 | 1987-02-18 | Beecham Group Plc | Treatment |
| IT1231413B (it) | 1987-09-23 | 1991-12-04 | Angeli Inst Spa | Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht |
| US5223511A (en) | 1987-09-23 | 1993-06-29 | Boehringer Ingelheim Italia S.P.A. | Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists |
| IT1226389B (it) | 1988-07-12 | 1991-01-15 | Angeli Inst Spa | Nuovi derivati ammidinici e guanidinici |
| NZ230068A (en) | 1988-07-29 | 1991-07-26 | Dainippon Pharmaceutical Co | Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions |
| EP0410509A1 (fr) | 1989-07-25 | 1991-01-30 | Duphar International Research B.V | Indazole-1H-carboxamides-3 substitués |
| JPH045289A (ja) | 1990-04-24 | 1992-01-09 | Hokuriku Seiyaku Co Ltd | アミド化合物 |
| JP3122671B2 (ja) | 1990-05-23 | 2001-01-09 | 協和醗酵工業株式会社 | 複素環式化合物 |
| HU211081B (en) | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
| ES2080482T3 (es) | 1990-12-28 | 1996-02-01 | Kyowa Hakko Kogyo Kk | Derivado de quinoleina. |
| NZ243993A (en) | 1991-08-20 | 1994-10-26 | Smithkline Beecham Plc | Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity |
| AU2491092A (en) | 1991-09-12 | 1993-04-05 | Smithkline Beecham Plc | Azabicyclic compounds as 5-ht4 receptor antagonists |
| MX9305947A (es) | 1992-09-29 | 1994-06-30 | Smithkline Beecham Plc | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
| US5571820A (en) | 1992-11-20 | 1996-11-05 | Taisho Pharmaceutical Co., Ltd. | Heterocyclic compound |
| TW251287B (fr) | 1993-04-30 | 1995-07-11 | Nissei Co Ltd | |
| GB9310582D0 (en) | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
| EP0748808A4 (fr) | 1994-02-28 | 1998-10-07 | Taisho Pharmaceutical Co Ltd | Compose heterocyclique |
| US5864039A (en) | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
| GB9406857D0 (en) | 1994-04-07 | 1994-06-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| JP3829879B2 (ja) | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
| CA2160420A1 (fr) | 1994-10-20 | 1996-04-21 | Haruhiko Kikuchi | Agonistes du recepteur 5-ht4 |
| JP3829880B2 (ja) | 1994-12-27 | 2006-10-04 | 大正製薬株式会社 | 化学中間体 |
| IT1275903B1 (it) | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
| US5654320A (en) | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
| EP0829474B1 (fr) | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Derives de l'indazole a groupe amino monocyclique |
| ES2109190B1 (es) | 1996-03-22 | 1998-07-01 | Univ Madrid Complutense | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
| IT1291569B1 (it) | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
| FR2762316B1 (fr) * | 1997-04-18 | 1999-12-17 | Sanofi Synthelabo | Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique |
| TW402591B (en) | 1997-07-11 | 2000-08-21 | Janssen Pharmaceutica Nv | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| US6069152A (en) | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| US5914405A (en) | 1997-10-07 | 1999-06-22 | Eli Lilly And Company | Process for preparing 3-substituted indazoles |
| FR2769915B1 (fr) | 1997-10-21 | 2000-10-13 | Synthelabo | Derives d'indazole tricycliques, leur preparation et leur application en therapeutique |
| IT1298271B1 (it) | 1998-02-18 | 1999-12-20 | Boehringer Ingelheim Italia | Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico |
| TWI242004B (en) | 1998-04-28 | 2005-10-21 | Dainippon Pharmaceutical Co | 1-(1-substituted-4-piperidinyl)methyl-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| ES2283132T3 (es) | 1998-09-10 | 2007-10-16 | F. Hoffmann-La Roche Ag | Dihidrobenzodiaxin carboxamida y derivados de cetona como antagonistas receptores de 5-ht4. |
| TW570920B (en) | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| FR2792318B1 (fr) | 1999-04-16 | 2001-06-15 | Synthelabo | Derives d'indazole, leur preparation et leur application en therapeutique |
| CN1461216A (zh) | 1999-04-28 | 2003-12-10 | 呼吸器有限公司 | 用作治疗有关支气管收缩的机能障碍的药物的化合物 |
| ES2154605B1 (es) | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
| IT1313625B1 (it) | 1999-09-22 | 2002-09-09 | Boehringer Ingelheim Italia | Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. |
| IT1313660B1 (it) | 1999-10-01 | 2002-09-09 | Dompe Spa | Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani. |
| AU2002212888A1 (en) | 2000-11-01 | 2002-05-15 | Respiratorius Ab | Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) |
| US6624162B2 (en) | 2001-10-22 | 2003-09-23 | Pfizer Inc. | Imidazopyridine compounds as 5-HT4 receptor modulators |
| MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
| US6696468B2 (en) | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| DOP2003000703A (es) | 2002-09-20 | 2004-03-31 | Pfizer | Compuestos de imidazopiradina como agonistas del receptor 5-ht4 |
| CA2499494A1 (fr) | 2002-09-20 | 2004-04-01 | Pfizer Inc. | Composes de piperidinyl-imidazopyridine n-substitues utilises comme modulateurs du recepteur 5-ht4 |
| EP1620435A1 (fr) | 2003-04-21 | 2006-02-01 | Pfizer Inc. | COMPOSES IMIDAZOPYRIDIQUES AYANT UNE ACTIVITE AGONISTE ANTI-RECEPTEUR 5-HT sb 4 /sb ET UNE ACTIVITE ANTAGONISTE ANTI-RECEPTEUR 5-HT sb 3 /sb |
| JO2478B1 (en) | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
| PL1641783T3 (pl) | 2003-06-19 | 2012-08-31 | Janssen Pharmaceutica Nv | 4-(aminometylo)-piperydyno-benzamidy podstawione aminosulfonylem jako antagoniści 5HT₄ |
| DK1664036T3 (da) | 2003-09-03 | 2012-02-13 | Pfizer | Benzimidazolonforbindelser med 5-HT4-receptoragonistisk virkning |
| JP4704353B2 (ja) | 2003-11-24 | 2011-06-15 | ファイザー株式会社 | ５−ｈｔ４受容体アゴニスト活性を有するキノリンカルボン酸化合物 |
| EP1713797B1 (fr) | 2004-01-29 | 2008-03-05 | Pfizer, Inc. | Derives de 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide presentant une activite agoniste du recepteur 5-ht4 |
| TW200533348A (en) | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| WO2005092882A1 (fr) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | Derives de 4-amino-5-halogeno-benzamide utiles comme agonistes du recepteur 5-ht4 dans le traitement des troubles gastro-intestinaux, du systeme nerveux central, neurologiques et cardio-vasculaires |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| US7728006B2 (en) | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US7737163B2 (en) | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
| EP1758891A2 (fr) | 2004-06-15 | 2007-03-07 | Pfizer Japan Inc. | Derives de benzimidazolone d'acide carboxylique |
| JP5042028B2 (ja) | 2004-11-05 | 2012-10-03 | セラヴァンス， インコーポレーテッド | キノリノン−カルボキサミド化合物 |
| ATE441646T1 (de) | 2004-11-05 | 2009-09-15 | Theravance Inc | 5-ht4-rezeptoragonistenverbindungen |
| US7317022B2 (en) * | 2005-06-07 | 2008-01-08 | Theravance, Inc. | Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists |
-
2005
- 2005-12-21 CA CA002588037A patent/CA2588037A1/fr not_active Abandoned
- 2005-12-21 CN CNA2005800433844A patent/CN101080406A/zh active Pending
- 2005-12-21 DE DE602005021696T patent/DE602005021696D1/de not_active Expired - Lifetime
- 2005-12-21 BR BRPI0519708-2A patent/BRPI0519708A2/pt not_active IP Right Cessation
- 2005-12-21 WO PCT/US2005/046295 patent/WO2006069125A1/fr not_active Ceased
- 2005-12-21 AT AT05854933T patent/ATE469897T1/de not_active IP Right Cessation
- 2005-12-21 KR KR1020077016579A patent/KR20070091665A/ko not_active Ceased
- 2005-12-21 NZ NZ555180A patent/NZ555180A/en not_active IP Right Cessation
- 2005-12-21 AU AU2005319190A patent/AU2005319190A1/en not_active Abandoned
- 2005-12-21 MX MX2007007818A patent/MX2007007818A/es active IP Right Grant
- 2005-12-21 JP JP2007548417A patent/JP5159317B2/ja not_active Expired - Fee Related
- 2005-12-21 RU RU2007128061/04A patent/RU2404179C2/ru not_active IP Right Cessation
- 2005-12-21 ES ES05854933T patent/ES2347265T3/es not_active Expired - Lifetime
- 2005-12-21 US US11/314,591 patent/US7419989B2/en not_active Expired - Lifetime
- 2005-12-21 EP EP05854933A patent/EP1831211B1/fr not_active Expired - Lifetime
-
2007
- 2007-05-14 IL IL183160A patent/IL183160A0/en unknown
- 2007-06-08 MA MA29976A patent/MA29088B1/fr unknown
- 2007-06-18 ZA ZA200705115A patent/ZA200705115B/xx unknown
- 2007-06-21 NO NO20073182A patent/NO20073182L/no not_active Application Discontinuation
-
2008
- 2008-01-15 US US12/008,840 patent/US7786136B2/en not_active Expired - Fee Related
-
2010
- 2010-07-23 US US12/842,389 patent/US8003664B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100292223A1 (en) | 2010-11-18 |
| EP1831211B1 (fr) | 2010-06-02 |
| RU2404179C2 (ru) | 2010-11-20 |
| DE602005021696D1 (de) | 2010-07-15 |
| US8003664B2 (en) | 2011-08-23 |
| ES2347265T3 (es) | 2010-10-27 |
| WO2006069125A1 (fr) | 2006-06-29 |
| JP5159317B2 (ja) | 2013-03-06 |
| CA2588037A1 (fr) | 2006-06-29 |
| IL183160A0 (en) | 2007-09-20 |
| RU2007128061A (ru) | 2009-01-27 |
| EP1831211A1 (fr) | 2007-09-12 |
| US20060135764A1 (en) | 2006-06-22 |
| ZA200705115B (en) | 2008-06-25 |
| US20080132491A1 (en) | 2008-06-05 |
| CN101080406A (zh) | 2007-11-28 |
| NZ555180A (en) | 2010-09-30 |
| NO20073182L (no) | 2007-08-28 |
| BRPI0519708A2 (pt) | 2009-03-10 |
| JP2008525466A (ja) | 2008-07-17 |
| US7786136B2 (en) | 2010-08-31 |
| KR20070091665A (ko) | 2007-09-11 |
| AU2005319190A1 (en) | 2006-06-29 |
| MX2007007818A (es) | 2007-09-11 |
| ATE469897T1 (de) | 2010-06-15 |
| US7419989B2 (en) | 2008-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA29088B1 (fr) | Composes d'indazole-carboxamide. | |
| MY155036A (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
| TW200531692A (en) | Aryl aniline derivatives as β2 adrenergic receptor agonists | |
| WO2005121065A3 (fr) | Agonistes des recepteurs $g(b)2-adrenergiques diaminiques | |
| TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| ATE431824T1 (de) | Chinolinon-carboxamid-verbindungen | |
| BRPI0507791A (pt) | compostos de indazol-carboxamida como agonistas do receptor 5-ht4 | |
| MX2009006339A (es) | Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide. | |
| CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
| CR9304A (es) | Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos | |
| WO2005030678A3 (fr) | Agonistes ethylamino aminosubstitues du recepteur ?eta2-adrenergique | |
| TW200608960A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| TW200608966A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| WO2006031556A3 (fr) | Composes d'arylaniline a substitution amidine | |
| WO2006047032A3 (fr) | Composes indole convenant comme agents selectifs par rapport a la serotonine | |
| WO2006133104A3 (fr) | Composes de benzoimidazolone-carboxamide en tant qu'agonistes du recepteur 5-ht4 | |
| UA83917C2 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
| NO20074884L (no) | Kinolinonforbindelser som 5-HT receptoragonister | |
| EA200702612A1 (ru) | Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт | |
| MY143574A (en) | Carbamate compounds as 5-ht4 receptor agonists | |
| UA83142C2 (en) | 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors | |
| TH75845A (th) | สารประกอบควิโนลิโนน-คาร์บอกแซมีดในฐานะเป็นแอกอนิสท์ของตัวรับ 5-ht4 |